PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $849,643 | -88.8% | 48,999 | -88.3% | 0.00% | -87.5% |
| Q2 2023 | $7,586,173 | -40.6% | 418,663 | -12.9% | 0.01% | -42.9% |
| Q1 2023 | $12,781,539 | +209.3% | 480,509 | +124.7% | 0.01% | +180.0% |
| Q4 2022 | $4,132,773 | -8.1% | 213,801 | -0.7% | 0.01% | 0.0% |
| Q3 2022 | $4,498,000 | +679.5% | 215,315 | +198.8% | 0.01% | +400.0% |
| Q2 2022 | $577,000 | -8.7% | 72,055 | -20.0% | 0.00% | 0.0% |
| Q1 2022 | $632,000 | -5.5% | 90,109 | +81.8% | 0.00% | 0.0% |
| Q4 2021 | $669,000 | -47.9% | 49,555 | -34.8% | 0.00% | 0.0% |
| Q3 2021 | $1,283,000 | -50.9% | 75,994 | -15.3% | 0.00% | -50.0% |
| Q2 2021 | $2,613,000 | -13.0% | 89,721 | +17.5% | 0.00% | -33.3% |
| Q1 2021 | $3,003,000 | – | 76,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |